CAR-T 12/10/2020 Improving the Flexibility and Predictability of CAR-T Manufacturing Getting CAR-T product pipelines to market faster: saving time, money and improving flexibility and predictability
CAR-T 30/09/2020 The Evolving Process of Clinical CAR-T Manufacturing in an Academic Setting A presentation with Isabelle Riviere, Director, Michael G. Harris Cell Therapy and Cell Engineering Laboratory at MSKCC
Investment for advanced therapies 08/07/2020 Mid-year Review of the Top Events in Advanced Therapies 2020 IPOs, acquisitions, Covid-19 and more...
Phacilitate Talks 22/05/2020 Episode 1: the impact of Covid-19 and Future Pandemics on Getting... Welcome to the first episode of Phacilitate Talks!
Academia 18/05/2020 The KOL’s View with Dr Philippe Menasche, University of Paris Episode four of the Phacilitate Leaders World 2020 super plenary series with Dr Philippe Menasche, Professor of Thoracic...
Bioprocessing 14/04/2020 The Biotech View with Michelle Simpson-Abelson, Iovance Therapeutics Episode two of the Phacilitate Leaders World 2020 super plenary series with Michelle Simpson-Abelson, Principle Scientist...
Commercialisation 03/02/2020 Top Ten Events in Advanced Therapies 2019 From patent infringements, a flurry of M&As, CRISPR trials in humans; Phacilitate's annual top ten list was revealed...
Technology innovation 11/12/2019 The Top 20 Advanced Therapy Biotechs to Watch in 2020 Who have you got your eye on?
Regulatory affairs 07/11/2019 Accelerating Advanced Therapy Treatments with the FDA’s RMAT... An introduction to the FDA’s RMAT designation with Dr Julie Allickson, Director, Regenerative Medicine Clinical Center at Wake...
Clinical trials 06/08/2019 Advanced Therapies Opportunities in Europe An overview of clinical, investment and market approval activity in Europe
patient access 25/06/2019 The Next Chapter Starts Here and Ends with a Cure Episode two with Nicole Gularte, Patient Advocate, Fight for Cures
patient access 23/06/2019 Patient Access and Delivery of Advanced Therapies - Part Two An interview with Dr Matthew Frigault, Instructor and Clinical Assistant in Medicine, Massachusetts General Hospital
Academia 01/10/2018 [INTERVIEW] An Academic Perspective on Cell Therapy, Trial Design... An interview with Dr David Courtman of the Ottawa Hospital, the University of Ottawa and Northern Therapeutics
Clinical trials 03/04/2018 The UK is a Leader in Preclinical Cell and Gene Therapy Research The UK has a rich and diverse range of preclinical research and is setting the foundations for the therapies of the future. The CGT Catapult’s...
Cell and gene therapy 15/02/2018 Infographic: Your Guide to Investing in Advanced Therapies In order to successfully invest in and realise the potential of advanced therapies, several technical factors must be well understood and...
